More on NAMS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $31.05 |
|
|||
| Open | $30.74 | ||||
| 52 Wk High | $0.00 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $32.09 | ||||
| Day Low | $30.70 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 704,411 | ||||
- Attovia Therapeutics names John Smither to board of directors
- Attovia Therapeutics Appoints John W. Smither to Board of Directors
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026
- NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026
- NewAmsterdam Pharma Co NV (NAMS) PT Raised to $51 at RBC Capital
- Form 4 NewAmsterdam Pharma Co For: Jun 22 Filed by: Kooij Louise Frederika
- NewAmsterdam Pharma (NAMS) call put ratio 1 call to 4.8 puts with a focus on 2K contracts of January 25 puts
- NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions
- NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June
Entities mentioned with NAMS
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- SPAC | View Related Stories »
- Jefferies & Co | View Related Stories »
- Earnings | View Related Stories »
- F1 | View Related Stories »
- Show More...
